Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Orfadin Oral Suspension (nitisinone)
pCPA File Number:
21158
Negotiation Status:
Concluded without agreement
Indication(s):
Hereditary Tyrosinemia Type 1
Sponsor/Manufacturer:
Sobi Canada Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
2019-08-09
Negotiation Process Concluded:
2020-03-30